PHIBRO ANIMAL HEALTH CORP
PAHCPhibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Aug 26, 2026
7wMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is PHIBRO ANIMAL HEALTH CORP's next FDA catalyst?→
PHIBRO ANIMAL HEALTH CORP's (PAHC) next tracked catalyst is a Earnings expected August 26, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track PAHC biotech catalysts?→
Add PAHC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PHIBRO ANIMAL HEALTH CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.